{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2248, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 28, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide highlights the composition of Valeant's business segments and justifies their attractiveness.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/28", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 29, "slideType": "segmentation", "function": "decompose_segments", "notes": "The slide uses a dot-matrix to visualize market presence by product type and region.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/29", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 30, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/30", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 31, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights that the durable business represents ~85% of total sales.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/31", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 32, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/32", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 33, "slideType": "problem_statement", "function": "diagnose_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/33", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 34, "slideType": "precedent_table", "function": "cite_precedent", "notes": "The slide uses media headlines as evidence of the financial risk associated with traditional R&D models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/34", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 35, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a bulleted list to define the company's R&D philosophy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/35", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 36, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/36", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 37, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/37", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 38, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a waterfall-style comparison to illustrate margin efficiency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/38", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 39, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/39", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 40, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/40", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 41, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/41", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 42, "slideType": "quote_slide", "function": "cite_precedent", "notes": "The slide contains two green callout boxes containing quotes, followed by the attribution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/42", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 43, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/43", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 44, "slideType": "ceo_quote", "function": "establish_context", "notes": "The slide uses a direct quote to frame the company's internal culture as a strategic choice.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/44", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 45, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/45", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 46, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a waterfall-style visual to contrast cost components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/46", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 47, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/47", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 48, "slideType": "thesis_headline", "function": "frame_problem", "notes": "The slide uses a simple numerical example to illustrate the 'valuation trap' of consolidated growth metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/48", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 49, "slideType": "appendix_disclosure", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/49", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-49", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 50, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "Uses a conceptual line chart to explain the 'patent cliff' impact on reported growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/50", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-50", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 51, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table highlights the performance of 'Total Product Sales' across different periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/51", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-51", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 52, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/52", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-52", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 53, "slideType": "quote_slide", "function": "cite_precedent", "notes": "The slide contains a primary quote block and a footnote reference.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/53", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-53", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 54, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/54", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-54", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 55, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a table to show the vesting schedule of performance share units (PSUs) based on annualized Total Shareholder Return (TSR).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/55", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-55", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 56, "slideType": "cite_precedent", "function": "cite_precedent", "notes": "The slide uses the 3G Capital case study as a precedent to validate Valeant's management philosophy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/56", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-56", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 57, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/57", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-57", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 58, "slideType": "ceo_quote", "function": "cite_precedent", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/58", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-58", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 59, "slideType": "thesis_headline", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/59", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-59", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 60, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a visual bracket to emphasize the cumulative difference between the two metrics over the three-year period.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/60", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-60", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 61, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide highlights specific accounting adjustments used by Valeant to inflate earnings metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/61", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-61", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 62, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a bridge-style reconciliation table to justify non-GAAP metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/62", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-62", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 63, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a table to contrast GAAP accounting practices with the author's economic view of the company's performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/63", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-63", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 64, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/64", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-64", "loopMatches": [ { "to": 69, "from": 64, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "96b6da1b-b7fe-4458-b004-ac1d3163a35f", "evidence": "The presentation notes that Allergan shareholders may miss out on value creation if the deal is not pursued", "position": 1, "objective": "To highlight the risks of not pursuing the Valeant acquisition", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 65, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "The slide uses a dual-axis chart to correlate share price (line) with volume (bars) and Pershing Square's specific purchase activity (dark bars).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/65", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-65", "loopMatches": [ { "to": 69, "from": 64, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "96b6da1b-b7fe-4458-b004-ac1d3163a35f", "evidence": "The presentation notes that Allergan shareholders may miss out on value creation if the deal is not pursued", "position": 1, "objective": "To highlight the risks of not pursuing the Valeant acquisition", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 66, "slideType": "appendix_data", "function": "analyze_data", "notes": "This slide provides factual evidence regarding the accumulation of an economic stake and the subsequent market reaction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/66", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-66", "loopMatches": [ { "to": 69, "from": 64, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "96b6da1b-b7fe-4458-b004-ac1d3163a35f", "evidence": "The presentation notes that Allergan shareholders may miss out on value creation if the deal is not pursued", "position": 1, "objective": "To highlight the risks of not pursuing the Valeant acquisition", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 67, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "This slide is likely part of a legal or regulatory filing (SEC) documenting market activity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/67", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-67", "loopMatches": [ { "to": 69, "from": 64, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "96b6da1b-b7fe-4458-b004-ac1d3163a35f", "evidence": "The presentation notes that Allergan shareholders may miss out on value creation if the deal is not pursued", "position": 1, "objective": "To highlight the risks of not pursuing the Valeant acquisition", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 68, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/68", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-68", "loopMatches": [ { "to": 69, "from": 64, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "96b6da1b-b7fe-4458-b004-ac1d3163a35f", "evidence": "The presentation notes that Allergan shareholders may miss out on value creation if the deal is not pursued", "position": 1, "objective": "To highlight the risks of not pursuing the Valeant acquisition", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 69, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/69", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-69", "loopMatches": [ { "to": 69, "from": 64, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "96b6da1b-b7fe-4458-b004-ac1d3163a35f", "evidence": "The presentation notes that Allergan shareholders may miss out on value creation if the deal is not pursued", "position": 1, "objective": "To highlight the risks of not pursuing the Valeant acquisition", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 70, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/70", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-70", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 71, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/71", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-71", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 72, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a 'drill-down' visual technique to show the composition of the 'Durable' segment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/72", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-72", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 73, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights that the analyst's 6-8% growth estimate is a slight discount to management's own projections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/73", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-73", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 74, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Uses red 'X' icons to emphasize the lack of comparability across four industry segments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/74", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-74", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 75, "slideType": "peer_benchmark", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/75", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-75", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 76, "slideType": "precedent_table", "function": "cite_precedent", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/76", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-76", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 77, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a comparison framework to justify valuation multiples by drawing parallels to a high-performing consumer sector.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/77", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-77", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 78, "slideType": "peer_benchmark", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/78", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-78", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 79, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "The chart uses a floating bar format to show ranges for three different comparable categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/79", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-79", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 80, "slideType": "appendix_methodology", "function": "summarize", "notes": "The slide details three specific conservative assumptions regarding life-cycle management, post-patent revenue, and cost variability.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/80", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-80", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 81, "slideType": "appendix_methodology", "function": "analyze_data", "notes": "The slide outlines the assumptions (10% discount rate, 10-year life, 0-5% growth) and presents a sensitivity table for DCF multiples.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/81", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-81", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 82, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "The table uses a weighted average approach based on earnings contribution to derive the base business multiple.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/82", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-82", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 83, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/83", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-83", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 84, "slideType": "thesis_headline", "function": "establish_context", "notes": "Features logos of Danaher, Liberty Media, ABInBev, and Jarden Corporation as examples of platform businesses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/84", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-84", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 85, "slideType": "before_after", "function": "illustrate_case", "notes": "The chart uses a timeline-based annotation style to correlate M&A activity with stock performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/85", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-85", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 86, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses 'The Outsiders' book principles as a framework for evaluating Jarden's management success.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/86", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-86", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9b-7e7228555e88", "docSlug": "36c903ba19aa", "documentTitle": "Allergan, Inc. (AGN)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-04-22 00:00:00", "orientation": "portrait", "aspectRatio": 0.70665085, "pageNumber": 87, "slideType": "other", "function": "establish_context", "notes": "This slide serves as a historical context piece for an activist investor's thesis regarding a specific executive's track record.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/87", "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-87", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }